Discovery of Novel Potent and Fast BTK PROTACs for the Treatment of Osteoclasts-Related Inflammatory Diseases
Junli Huang,Zeli Ma,Xiaopeng Peng,Zichao Yang,Yuhao Wu,Guanghong Zhong,Tianfeng Ouyang,Zhen Chen,Yao Liu,Qirui Wang,Jianjun Chen,Ting Chen,Zhenhua Zeng
DOI: https://doi.org/10.1021/acs.jmedchem.3c01414
IF: 8.039
2024-02-07
Journal of Medicinal Chemistry
Abstract:Bruton's tyrosine kinase (BTK) is an attractive target in inflammatory and autoimmune diseases. However, the effectiveness of BTK inhibitors is limited by side effects and drug resistance. In this study, we report the development of novel BTK proteolysis targeting chimeras (PROTACs) with different classes of BTK-targeting ligands (e.g., spebrutinib) other than ibrutinib. Compound 23 was identified as a potent and fast BTK PROTAC degrader, exhibiting outstanding degradation potency and efficiency...
chemistry, medicinal
What problem does this paper attempt to address?